17530361

Source:http://linkedlifedata.com/resource/pubmed/id/17530361

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0009429, umls-concept:C0019169, umls-concept:C0205466, umls-concept:C0209738, umls-concept:C0332281, umls-concept:C0540694, umls-concept:C0556895, umls-concept:C0871261, umls-concept:C1521761, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	5
pubmed:dateCreated	2007-5-28
pubmed:abstractText	The aim of this study was to investigate the factors associated with the response of lamivudine-resistant hepatitis B virus (HBV) during combination therapy with adefovir dipivoxil plus lamivudine.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9430794
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adenine, http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase, http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/DNA, Viral, http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis B e Antigens, http://linkedlifedata.com/resource/pubmed/chemical/Lamivudine, http://linkedlifedata.com/resource/pubmed/chemical/Phosphonic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/adefovir dipivoxil
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0944-1174
pubmed:author	pubmed-author:AkutaNorioN, pubmed-author:AraseYasujiY, pubmed-author:HosakaTetsuyaT, pubmed-author:IkedaKenjiK, pubmed-author:KobayashiMasahiroM, pubmed-author:KumadaHiromitsuH, pubmed-author:SaitohSatoshiS, pubmed-author:SezakiHitomiH, pubmed-author:SomeyaTakashiT, pubmed-author:SuzukiFumitakaF, pubmed-author:SuzukiYoshiyukiY
pubmed:issnType	Print
pubmed:volume	42
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	368-74
pubmed:meshHeading	pubmed-meshheading:17530361-Adenine, pubmed-meshheading:17530361-Adult, pubmed-meshheading:17530361-Aged, pubmed-meshheading:17530361-Alanine Transaminase, pubmed-meshheading:17530361-Antiviral Agents, pubmed-meshheading:17530361-DNA, Viral, pubmed-meshheading:17530361-Drug Therapy, Combination, pubmed-meshheading:17530361-Female, pubmed-meshheading:17530361-Hepatitis, pubmed-meshheading:17530361-Hepatitis B e Antigens, pubmed-meshheading:17530361-Hepatitis B virus, pubmed-meshheading:17530361-Humans, pubmed-meshheading:17530361-Lamivudine, pubmed-meshheading:17530361-Male, pubmed-meshheading:17530361-Middle Aged, pubmed-meshheading:17530361-Multivariate Analysis, pubmed-meshheading:17530361-Phosphonic Acids, pubmed-meshheading:17530361-Retrospective Studies, pubmed-meshheading:17530361-Reverse Transcriptase Inhibitors
pubmed:year	2007
pubmed:articleTitle	Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine.
pubmed:affiliation	Department of Gastroenterology, Toranomon Hospital, 2-2-2 Toranomon, Tokyo 105-8470, Japan.
pubmed:publicationType	Journal Article